Genmab — Maj 2020
-
God morgen
-
ASCO: J&J 's anti - BCMA CAR-T improving with time sweeps Multiple Myeloma aside. https://www.fiercebiotech.com/biotech/asco-j-j-s-anti-bcma-car-t-improving-time-clears-multiple-myeloma?mkt_tok=eyJpIjoiWXpVME9USTBNRFF3T1RRNCIsInQiOiJoK21GN3phdVBuQkppUFwveVVidTMyVFcrbGVaaVZUZEcwTU9xemQwNFZ2dHNnK2lwSHl6VUNDNHFLOVZqRkdTeEgyVzE1b2YwTDNkeURiVE5SNllaVVI5TEN5WHR4WVA3NEp4bFNka2h5eHZtckNDcnU3VFlyMWlDVFwvdG1wTFhhM3lEVjBqMGR0OWFuWUczaFwvbmVTQlE9PSJ9&mrkid=41140432
-
Daratumumab treatment in heavely pre-treated
immunoglobulin light chain amyloidosis https://cme-congresses.com/mailshotcme/COMy/2020/Abstracts/9.pdf -
I still hope we will get that epcorita mab deal before ASCO - so my guess is either this weekend or next weekend. I would be nice to get that extra attention at ASCO. Maybe even more important in these Corona times so Genmab and Partner can keep this project moving as fast as possible
-
4544 / 12 - Multifaceted mechanism of action of DuoHexaBody-CD37 involves both complement- and Fc gamma receptor-mediated cytotoxicity in pre-clinical B-cell lymphoma models https://www.abstractsonline.com/pp8/#!/9045/presentation/7694
-
JNJ-61186372, an EGFR-cMet bispecific antibody, in EGFR Exon 20 insertion-driven advanced non-small cell lung cancer (NSCLC) https://www.abstractsonline.com/pp8/#!/9045/presentation/5116
-
JNJ-61186372, an Fc enhanced EGFR/cMet bispecific antibody, mediates EGFR and cMet downmodulation and therapeutic efficacy preclinically through monocyte / macrophage mediated trogocytosis https://www.abstractsonline.com/pp8/#!/9045/presentation/7722
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind